China Universal Asset Management »

Iteos Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $94k 6.9k 13.67
2023-12-31 $45k 4.1k 10.87
2023-09-30 $10k 924 10.82
2023-06-30 $6.0k 469 12.79
2023-03-31 $7.0k 482 14.52
2022-12-31 $7.0k 361 19.39
2022-09-30 $6.0k 333 18.02

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Iteos Therapeutics

RA Capital Management
Boxer Capital
Vanguard Group
BVF
Citadel Advisors
EcoR1 Capital
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Deerfield Management Company
683 Capital Management
Jacobs Levy Equity Management
Artal Group
Ikarian Capital
Citigroup

View all funds holding Iteos Therapeutics